Literature DB >> 11226126

Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.

P J Millns1, V Chapman, D A Kendall.   

Abstract

Cannabinoids have marked inhibitory effects on somatosensory processing, which may arise from actions at both peripheral and central cannabinoid receptors. Here, the effect of a synthetic cannabinoid agonist HU210 on capsaicin-evoked responses in adult rat dorsal root ganglion (DRG) neurones was studied. The vanilloid capsaicin produced a concentration-related increase in intracellular calcium in DRG neurones, which was significantly inhibited by HU210 (1 microM). The cannabinoid CB(1) receptor antagonist SR141716A (1 microM) had no effect alone and did not influence the response to capsaicin but significantly reversed the inhibitory effect of HU210. These data indicate that DRG CB(1) receptors are functional and can inhibit nociceptive responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226126      PMCID: PMC1572657          DOI: 10.1038/sj.bjp.0703919

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Cannabinoid CB(1) receptor expression in rat spinal cord.

Authors:  W P Farquhar-Smith; M Egertová; E J Bradbury; S B McMahon; A S Rice; M R Elphick
Journal:  Mol Cell Neurosci       Date:  2000-06       Impact factor: 4.314

2.  Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.

Authors:  L J Drew; J Harris; P J Millns; D A Kendall; V Chapman
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

3.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

4.  Characterization of two cloned human CB1 cannabinoid receptor isoforms.

Authors:  M Rinaldi-Carmona; B Calandra; D Shire; M Bouaboula; D Oustric; F Barth; P Casellas; P Ferrara; G Le Fur
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

5.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

6.  Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo.

Authors:  J Harris; L J Drew; V Chapman
Journal:  Neuroreport       Date:  2000-08-21       Impact factor: 1.837

7.  Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries.

Authors:  V Ralevic; D A Kendall; M D Randall; P M Zygmunt; P Movahed; E D Högestätt
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  Bidirectional control of airway responsiveness by endogenous cannabinoids.

Authors:  A Calignano; I Kátona; F Désarnaud; A Giuffrida; G La Rana; K Mackie; T F Freund; D Piomelli
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

9.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

10.  Capsaicin sensitivity is associated with the expression of the vanilloid (capsaicin) receptor (VR1) mRNA in adult rat sensory ganglia.

Authors:  R J Helliwell; L M McLatchie; M Clarke; J Winter; S Bevan; P McIntyre
Journal:  Neurosci Lett       Date:  1998-07-10       Impact factor: 3.046

View more
  13 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

2.  Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling.

Authors:  Barbara Bosier; Pierre J Doyen; Amandine Brolet; Giulio G Muccioli; Eman Ahmed; Nathalie Desmet; Emmanuel Hermans; Ronald Deumens
Journal:  Br J Pharmacol       Date:  2015-10-25       Impact factor: 8.739

Review 3.  Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?

Authors:  Amber L Milligan; Thomas A Szabo-Pardi; Michael D Burton
Journal:  J Dual Diagn       Date:  2019-10-09

4.  Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.

Authors:  Carl Potenzieri; Thaddeus S Brink; Cholawat Pacharinsak; Donald A Simone
Journal:  J Neurophysiol       Date:  2008-09-10       Impact factor: 2.714

5.  Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.

Authors:  Marnie Duncan; Paul Millns; Darren Smart; James E Wright; David A Kendall; Vera Ralevic
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

6.  Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons.

Authors:  Z-Y Wang; T McDowell; P Wang; R Alvarez; T Gomez; D E Bjorling
Journal:  Neuroscience       Date:  2014-08-01       Impact factor: 3.590

7.  The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.

Authors:  Carl Potenzieri; Catherine Harding-Rose; Donald A Simone
Journal:  Brain Res       Date:  2008-04-06       Impact factor: 3.252

8.  Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk.

Authors:  R M Evans; R H Scott; R A Ross
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

9.  Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist.

Authors:  Liliane J Dableh; Kiran Yashpal; James L Henry
Journal:  Eur J Pharmacol       Date:  2008-11-09       Impact factor: 4.432

10.  The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms.

Authors:  Mohammad Alsalem; Amy Wong; Paul Millns; Pallavi Huma Arya; Michael Siang Liang Chan; Andrew Bennett; David A Barrett; Victoria Chapman; David A Kendall
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.